Compounds > sc 58125
Page last updated: 2024-09-03

sc 58125 and isoxazoles

sc 58125 has been researched along with isoxazoles in 3 studies

Compound Research Comparison

Studies
(sc 58125)		Trials
(sc 58125)		Recent Studies (post-2010)
(sc 58125)		Studies
(isoxazoles)		Trials
(isoxazoles)		Recent Studies (post-2010) (isoxazoles)
930158,6339003,337

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernstein, SH; Chiorazzi, N; Felgar, RE; Kaur, K; Phipps, RP; Pollock, SJ; Ryan, EP1
Bushnell, TP; Friedman, AE; Phipps, RP; Rahman, I; Ryan, EP1
Hara, A; Hirose, Y; Hoshino, T; Murashita, H; Tabuchi, K; Tobita, T; Uemaetomari, I1

Other Studies

3 other study(ies) available for sc 58125 and isoxazoles

ArticleYear
Constitutive and activation-inducible cyclooxygenase-2 expression enhances survival of chronic lymphocytic leukemia B cells.
    Clinical immunology (Orlando, Fla.), 2006, Volume: 120, Issue:1

    Topics: B-Lymphocytes; Cell Growth Processes; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprost; Dinoprostone; Enzyme Activation; Humans; Immunoglobulin Heavy Chains; Immunohistochemistry; Indomethacin; Isoxazoles; Leukemia, Lymphocytic, Chronic, B-Cell; Nitrobenzenes; Pyrazoles; Sulfonamides; Sulfones; Thromboxane A2

2006
Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells.
    Cancer immunology, immunotherapy : CII, 2008, Volume: 57, Issue:3

    Topics: Animals; B-Lymphocytes; Catalytic Domain; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Glutamate-Cysteine Ligase; Glutathione; Humans; Isoxazoles; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Mice; Mice, Knockout; Oxidative Stress; Pyrazoles; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Sulfones

2008
The non-steroidal anti-inflammatory drugs protect mouse cochlea against acoustic injury.
    The Tohoku journal of experimental medicine, 2008, Volume: 216, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Auditory Threshold; Cochlea; Cyclooxygenase 1; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Evoked Potentials, Auditory, Brain Stem; Hair Cells, Auditory; Hearing Loss, Noise-Induced; Indomethacin; Isoxazoles; Lipoxygenase Inhibitors; Masoprocol; Meloxicam; Mice; Mice, Inbred Strains; Neuroprotective Agents; Pyrazoles; Sulfones; Thiazines; Thiazoles

2008